
News|Articles|January 27, 2016
A conversation with Centroflora CMS
Andrew Badrot, founder and CEO of Centroflora CMS, discussed the acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio with Pharmaceutical Technology.
Advertisement
Centroflora CMS, a joint venture between phytochemicals expert Centroflora from Brazil and the Swiss contract manufacturing organization (CMO) CMS Pharma, won the CPhI 2015 award for excellence in partnering and outsourcing for the way it handled its acquisition and technical transfer of Boehringer Ingelheim’s (BI) non-captive phytochemical API portfolio in 2014. Andrew Badrot, founder and CEO of Centroflora CMS, discussed the project with Pharmaceutical Technology.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%
4
EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development
5




